3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
2
Sponsor Class
OTHER
2
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other neoplasm
1
Genitourinary
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenomatous Polyps
1
Interventions
Radiotherapy
87
Cyclophosphamide
84
Cisplatin
79
Doxorubicin
66
Vincristine
62
Paclitaxel
55
Etoposide
50
Carboplatin
49
Filgrastim
48
Methotrexate
41
Prednisone
40
Cytarabine
37
Granulocyte Colony-Stimulating Factor
35
Radiotherapy, Intensity-Modulated
31
Platinum
31
Docetaxel
31
Gemcitabine
30
Leucovorin
28
Dexamethasone
28
Radiotherapy, Conformal
27
Fluorouracil
27
Cetuximab
26
Taxes
24
Rituximab
23
Irinotecan
23
1,2-diaminocyclohexaneplatinum II citrate
23
Radiation
21
merphos
20
Bevacizumab
19
Temozolomide
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Has results
×
alpha-Tocopherol
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts
NCT00006392
2015-11-20
SELECT
SWOG Cancer Research Network
Phase 3
Completed
35,533 enrolled
20 charts